AI Summary

Researchers at the University of Massachusetts Amherst have created an AI model that generates a patient’s radiation dose map for radiopharmaceutical therapy with gold‑standard accuracy in under 23 seconds. The tool addresses the current one‑size‑fits‑all dosing approach used in prostate cancer treatment, which the model argues leaves therapy potential untapped. By measuring how much radiation each tissue absorbs, the AI enables more personalized dosing. The development follows the recent FDA approval of RPT for prostate cancer and reflects ongoing industry investment in the field.

AI summaries can be wrong sometimes—always verify important details using the source article.